Whole sample | ||||||
---|---|---|---|---|---|---|
Regression1 | IncrementalWTP2 (£) | Their preference is for: | ||||
Value | (SD) | Value | (SD) | |||
ASC SURGERY | Coefficient | 1.4200 | (0.253) | 458.06 | - | Surgery (compared with current situation) |
ASC CREAM | Coefficient | 2.8700 | (0.398) | 925.81 | - | Imiquimod cream (comparedwith current situation) |
COST | Coefficient | −0.0031 | (0.000) | - | - | Decreased cost |
CHANCE | Mean | 0.1090 | (0.018) | 35.16 | (38.71) | increased chance, 82% of respondents |
SD | 0.1200 | (0.022) | ||||
MILD SIDE EFFECTS | Mean | 1.3800 | (0.314) | 445.16 | (541.94) | mild side effects (comparedwith severe, 79% of respondents) |
SD | 1.6800 | (0.282) | ||||
MODERATE SIDE EFFECTS | Mean | 0.8390 | (0.265) | 270.65 | (199.68) | moderate side effects (compared withsevere, 91% of respondents) |
SD | 0.6190 | (0.396) | ||||
NORMAL APPEARANCE | Mean | 1.0200 | (0.265) | 329.03 | (267.74) | normal appearance (compared withsevere change, 89% of respondents) |
SD | 0.8300 | (0.333) | ||||
MODERATE CHANGEIN APPEARANCE | Mean | 0.5400 | (0.345) | 174.19 | (548.39) | moderate change (compared withsevere change, 62% of respondents) |
SD | 1.7000 | (0.274) | ||||
Number of respondents | 174 | |||||
Number of observations | 2765 (=171 respondents *16 choices +1respondents*14 choices+1 respondent*8 choices+1 respondent*7 choices) | |||||
Log-likelihood | −2013.9 | |||||
Adjusted Rho-square | 0.333 | |||||
LR statistic | 2047.47 |